Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
Clinical trial NCT04796194 · COMPLETED
Trial details
- NCT number
- NCT04796194
- Sponsor
- Lytix Biopharma AS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2025-02-03
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.